Alrex

Chickenpox, Iritis, Inflammation + 10 more

Treatment

14 FDA approvals

20 Active Studies for Alrex

What is Alrex

Loteprednol

The Generic name of this drug

Alrex

is the brand name

image of different drug pills on a surface

Alrex Overview & Background

Brand Name

Generic Name

First FDA Approval

How many FDA approvals?

Alrex

Loteprednol

1998

16

Approved as Treatment by the FDA

Loteprednol, otherwise called Alrex, is approved by the FDA for 14 uses like Ocular Inflammation and ocular bacterial infections .

Ocular Inflammation

ocular bacterial infections

Used to treat ocular bacterial infections in combination with Tobramycin

Iritis

Inflammation

Used to treat Inflammation in combination with Tobramycin

Conjunctivitis infective

Seasonal Allergic Conjunctivitis

Conjunctivitis

Herpes Zoster Keratitis

Helps manage Herpes Zoster Keratitis

Inflammation

Used to treat Inflammation in combination with Tobramycin

Conjunctivitis

Iritis

Eye

Cyclitis

Superficial punctate keratitis

Helps manage Superficial punctate keratitis

When to interrupt dosage

The amount of Alrex is contingent upon the determined condition, including Ocular Inflammation, Conjunctivitis infective and Herpes Zoster Keratitis. The measure of dosage fluctuates as per the delivery technique (e.g. Gel - Ophthalmic or Suspension / drops) featured in the table underneath.

Condition

Dosage

Administration

Inflammation

, 2.0 mg/mL, 0.005 mg/mg, 5.0 mg/mL, 0.2 %, 0.5 %

Ophthalmic, Suspension / drops, Suspension / drops - Ophthalmic, , Ointment, Ointment - Ophthalmic, Suspension - Ophthalmic, Suspension, Gel, Gel - Ophthalmic

Rosacea

, 2.0 mg/mL, 0.005 mg/mg, 5.0 mg/mL, 0.2 %, 0.5 %

Ophthalmic, Suspension / drops, Suspension / drops - Ophthalmic, , Ointment, Ointment - Ophthalmic, Suspension - Ophthalmic, Suspension, Gel, Gel - Ophthalmic

Conjunctivitis

, 2.0 mg/mL, 0.005 mg/mg, 5.0 mg/mL, 0.2 %, 0.5 %

Ophthalmic, Suspension / drops, Suspension / drops - Ophthalmic, , Ointment, Ointment - Ophthalmic, Suspension - Ophthalmic, Suspension, Gel, Gel - Ophthalmic

Conjunctivitis

, 2.0 mg/mL, 0.005 mg/mg, 5.0 mg/mL, 0.2 %, 0.5 %

Ophthalmic, Suspension / drops, Suspension / drops - Ophthalmic, , Ointment, Ointment - Ophthalmic, Suspension - Ophthalmic, Suspension, Gel, Gel - Ophthalmic

Cyclitis

, 2.0 mg/mL, 0.005 mg/mg, 5.0 mg/mL, 0.2 %, 0.5 %

Ophthalmic, Suspension / drops, Suspension / drops - Ophthalmic, , Ointment, Ointment - Ophthalmic, Suspension - Ophthalmic, Suspension, Gel, Gel - Ophthalmic

Eye

, 2.0 mg/mL, 0.005 mg/mg, 5.0 mg/mL, 0.2 %, 0.5 %

Ophthalmic, Suspension / drops, Suspension / drops - Ophthalmic, , Ointment, Ointment - Ophthalmic, Suspension - Ophthalmic, Suspension, Gel, Gel - Ophthalmic

Chickenpox

, 2.0 mg/mL, 0.005 mg/mg, 5.0 mg/mL, 0.2 %, 0.5 %

Ophthalmic, Suspension / drops, Suspension / drops - Ophthalmic, , Ointment, Ointment - Ophthalmic, Suspension - Ophthalmic, Suspension, Gel, Gel - Ophthalmic

Communicable Diseases

, 2.0 mg/mL, 0.005 mg/mg, 5.0 mg/mL, 0.2 %, 0.5 %

Ophthalmic, Suspension / drops, Suspension / drops - Ophthalmic, , Ointment, Ointment - Ophthalmic, Suspension - Ophthalmic, Suspension, Gel, Gel - Ophthalmic

Superficial punctate keratitis

, 2.0 mg/mL, 0.005 mg/mg, 5.0 mg/mL, 0.2 %, 0.5 %

Ophthalmic, Suspension / drops, Suspension / drops - Ophthalmic, , Ointment, Ointment - Ophthalmic, Suspension - Ophthalmic, Suspension, Gel, Gel - Ophthalmic

ocular bacterial infections

, 2.0 mg/mL, 0.005 mg/mg, 5.0 mg/mL, 0.2 %, 0.5 %

Ophthalmic, Suspension / drops, Suspension / drops - Ophthalmic, , Ointment, Ointment - Ophthalmic, Suspension - Ophthalmic, Suspension, Gel, Gel - Ophthalmic

Iritis

, 2.0 mg/mL, 0.005 mg/mg, 5.0 mg/mL, 0.2 %, 0.5 %

Ophthalmic, Suspension / drops, Suspension / drops - Ophthalmic, , Ointment, Ointment - Ophthalmic, Suspension - Ophthalmic, Suspension, Gel, Gel - Ophthalmic

Seasonal Allergic Conjunctivitis

, 2.0 mg/mL, 0.005 mg/mg, 5.0 mg/mL, 0.2 %, 0.5 %

Ophthalmic, Suspension / drops, Suspension / drops - Ophthalmic, , Ointment, Ointment - Ophthalmic, Suspension - Ophthalmic, Suspension, Gel, Gel - Ophthalmic

Herpes Zoster Keratitis

, 2.0 mg/mL, 0.005 mg/mg, 5.0 mg/mL, 0.2 %, 0.5 %

Ophthalmic, Suspension / drops, Suspension / drops - Ophthalmic, , Ointment, Ointment - Ophthalmic, Suspension - Ophthalmic, Suspension, Gel, Gel - Ophthalmic

Warnings

Alrex has eight contraindications, so it should not be employed when confronting any of the circumstances detailed in the following table.

Alrex Contraindications

Condition

Risk Level

Notes

Keratitis, Dendritic

Do Not Combine

conjunctiva

Do Not Combine

Herpes Simplex

Do Not Combine

Chickenpox

Do Not Combine

Vaccinia

Do Not Combine

epithelial herpes simplex keratitis

Do Not Combine

Eye Infections, Fungal

Do Not Combine

Severe Hypersensitivity Reactions

Do Not Combine

Loteprednol may interact with Pulse Frequency

There are 20 known major drug interactions with Alrex.

Common Alrex Drug Interactions

Drug Name

Risk Level

Description

2,4-thiazolidinedione

Moderate

The risk or severity of hyperglycemia can be increased when Loteprednol is combined with 2,4-thiazolidinedione.

AICA ribonucleotide

Moderate

The risk or severity of hyperglycemia can be increased when Loteprednol is combined with AICA ribonucleotide.

AMG-222

Moderate

The risk or severity of hyperglycemia can be increased when Loteprednol is combined with AMG-222.

Acarbose

Moderate

The risk or severity of hyperglycemia can be increased when Loteprednol is combined with Acarbose.

Acetohexamide

Moderate

The risk or severity of hyperglycemia can be increased when Loteprednol is combined with Acetohexamide.

image of a doctor in a lab doing drug, clinical research

Alrex Novel Uses: Which Conditions Have a Clinical Trial Featuring Alrex?

198 active studies are currently being conducted to evaluate the potential of Alrex in alleviating Seasonal Allergic Conjunctivitis, Iritis and Ocular Inflammation.

Condition

Clinical Trials

Trial Phases

Eye

0 Actively Recruiting

Conjunctivitis

0 Actively Recruiting

Communicable Diseases

0 Actively Recruiting

Superficial punctate keratitis

0 Actively Recruiting

Iritis

0 Actively Recruiting

Herpes Zoster Keratitis

0 Actively Recruiting

Rosacea

2 Actively Recruiting

Early Phase 1, Phase 2

Conjunctivitis

0 Actively Recruiting

ocular bacterial infections

0 Actively Recruiting

Chickenpox

3 Actively Recruiting

Phase 3

Cyclitis

0 Actively Recruiting

Inflammation

57 Actively Recruiting

Not Applicable, Phase 1, Phase 2, Early Phase 1, Phase 3, Phase 4

Seasonal Allergic Conjunctivitis

0 Actively Recruiting

Alrex Reviews: What are patients saying about Alrex?

5

Patient Review

4/12/2009

Alrex for Herpes Zoster Infection of the Cornea & Conjunctiva of Eye

Allergies are such a pain, but this medication really does the trick. It's the only thing that's worked for me in the past. However, I understand why my doctor is hesitant to prescribe it because of the potential risks involved.

5

Patient Review

11/10/2011

Alrex for Inflammation of the Eye

Alrex provided quick and long-lasting relief from the incessant itchiness in my eyes.

5

Patient Review

9/7/2012

Alrex for Inflammation of the Eye

Alrex is very effective for chronic inflammation, which I experience due to several conditions. The only downside is the cost of the medication.

5

Patient Review

3/13/2009

Alrex for Allergic Conjunctivitis

I had some redness in my eye this morning, but after using Alrex just once today, it's already clearing up. I'm confident that it'll be gone completely soon.

5

Patient Review

11/22/2009

Alrex for Allergic Conjunctivitis

This medication has been a great help for my chronic inflammation of the eye and eyelids. It's helped to reduce the swelling and redness, and has made my eyes much more clear and white. I use it 3 times a day for 3 weeks, and it's really helped with the pain with no side effects.

5

Patient Review

6/13/2009

Alrex for Inflammation of the Eye

After three years of struggling with the zoster infection, this treatment finally gave me relief.

4

Patient Review

1/27/2009

Alrex for Allergic Conjunctivitis

My doctor recommended this treatment to me for slight redness in the corners of my eyes. It worked great at first, but now the effects have worn off slightly. Sometimes my eyes throb after using it.

3.7

Patient Review

1/17/2008

Alrex for Dilation of the Blood Vessels of the Eye

I've been using this medication for "dry eye" for two years now. I originally started because over-the-counter treatments weren't helping me, but I haven't seen much relief from this drug either. Furthermore, I recently read that these types of medications can cause glaucoma. So, all things considered, I've decided to stop taking it.

2.7

Patient Review

3/15/2010

Alrex for Inflammation of the Eye

I've been using this for three days now and, unfortunately, have seen no improvement. My eyes are still red and itchy, and the watering hasn't stopped.

2.7

Patient Review

11/3/2007

Alrex for Raised Spots on the Cornea of the Eye

2.3

Patient Review

4/7/2012

Alrex for Raised Spots on the Cornea of the Eye

I saw no improvement after using as directed by my physician. In fact, my symptoms got worse.

2.3

Patient Review

10/22/2022

Alrex for Allergic Conjunctivitis

The pressure I felt when using this medication was intense and unbearable. It gave me a migraine and made me nauseous. The next day I felt dizzy and foggy. Overall, it was a terrible experience that did the opposite of what I intended to use it for.

1.3

Patient Review

12/29/2012

Alrex for Inflammation of the Eye

This medication did not clear up the issue of my red eyelids and eyes. Not only that, but they were also sore to the touch.
image of drug pills surrounding a glass of water symbolizing drug consumption

Patient Q&A Section about alrex

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Can you get Alrex over the counter?

"There is no version of Alrex available in the United States that is the same as what is being sold online. Note: Some online pharmacies may be selling a generic version of Alrex illegally."

Answered by AI

Is Alrex a steroid?

"Alrex is a steroid medicine that is used to treat various forms of eye inflammation, pain, and swelling. Alrex is also used to treat dry eye disease."

Answered by AI

How long can I use Alrex?

"Length of treatment: This medication is only meant to be used for a short period of time, no more than 14 days. If you use this medication for 10 days or more, your doctor will need to check the pressure in your eye regularly to make sure it doesn't cause any damage such as cataracts or glaucoma."

Answered by AI

What are Alrex eye drops used for?

"This drug is designed to temporarily relieve seasonal allergy symptoms in the eyes, such as swelling, redness, and itching. Loteprednol is a type of drug known as a corticosteroid."

Answered by AI

Clinical Trials for Alrex

Image of Exercise and Performance Nutrition Laboratory in Saint Charles, United States.

Multi-Strain Postbiotic for Inflammation and Gastrointestinal Symptoms

18 - 55
All Sexes
Saint Charles, MO

This study will evaluate the effects of a multi-strain postbiotic supplement on markers of inflammation, immune function, gastrointestinal symptoms, psychological well-being, and intestinal permeability in healthy adults. The primary objective is to determine whether four weeks of postbiotic supplementation alters physiological and perceptual responses to a standardized bout of moderate-to-high intensity exercise compared with placebo. Approximately 50 healthy men and women aged 18 to 55 years will be enrolled in a randomized, double-blind, placebo-controlled, parallel-group clinical trial. Participants will be randomly assigned to receive either a multi-strain postbiotic supplement or a matched placebo for 28 days. At the end of the supplementation period, participants will complete a 45-minute treadmill exercise bout at 75% of their individually determined maximum heart rate. Blood samples will be collected to assess biomarkers of inflammation, immune activity, and recovery. Gastrointestinal symptoms, intestinal permeability, anxiety, and perceived recovery will be evaluated using validated questionnaires. This study is designed to determine whether postbiotic supplementation modulates physiological stress responses and subjective well-being following prolonged exercise in healthy adults.

Waitlist Available
Paid Trial

Exercise and Performance Nutrition Laboratory

Chad M Kerksick, PhD

Image of ATX Hyperbarics in Austin, United States.

Hyperbaric Oxygen Therapy for Cardiovascular Fitness

30 - 60
All Sexes
Austin, TX

The purpose of this study is to determine whether hyperbaric oxygen therapy (HBOT) at 1.75 atmospheres of pressure (ATA) improves cardiovascular fitness (VO₂ max) and reduces inflammation in healthy adults. HBOT involves breathing pure oxygen in a pressurized chamber and is considered investigational for this use. Recent research has shown that different HBOT pressures can have different effects on inflammation. Specifically, some inflammatory cytokines (measurable markers of inflammation in the body) appear to decrease at low pressures like 1.3 ATA, while a different set of cytokines responds better at higher pressures, such as 2.0 ATA. Cytokines are small proteins that play a crucial role in cell signaling, particularly within the immune system. They help regulate inflammation, infection response, and overall immune function. While some cytokines promote inflammation to fight off threats, others help reduce inflammation when it's no longer needed. An imbalance in cytokines - especially excessive inflammatory cytokines - can contribute to chronic inflammation, cardiovascular disease, and other health issues. In this study, we are testing an intermediate pressure - 1.75 ATA - to see if we can target both sets of cytokines at once. If successful, this approach could offer broader anti-inflammatory benefits. We are also interested in how this intermediate pressure may improve VO₂ max, a key indicator of cardiovascular fitness. Since VO₂ max is strongly linked to heart health and overall longevity, finding a safe and effective way to improve it has meaningful implications not just for athletes, but for anyone looking to enhance their fitness and well-being.

Recruiting
Has No Placebo

ATX Hyperbarics (+1 Sites)

Image of Montana State University in Bozeman, United States.

Haskap Berries for Exercise Performance Recovery

18 - 35
All Sexes
Bozeman, MT

The purpose of this clinical trial is to determine how certain food items affect oxidative stress, inflammation, and performance recovery from exercise induced muscle damage in a resistance trained population. The main questions The investigators aim to answer are the following: * Do Haskaps speed the recovery of oxidative stress and inflammation markers after an intense lower body workout in resistance trained adults? * Do Haskaps speed the recovery of performance measures after an intense lower body workout in resistance trained adults? * The data collected in this investigation may also be used to ask additional questions not yet identified. For example, the investigators may use the stored samples to evaluate how the blood metabolites of participants differ before and after intense exercise. These additional questions are called secondary analyses. Please note that no genetic analysis will be conducted and racial and ethnic differences among participants will not be used in any secondary analyses. Researches will compare Haskap juice to a color, flavor and carbohydrate matched placebo to see if Haskaps speed recovery in inflammation, oxidative stress and performance. * Participants will be asked to drink either Haskap juice or placebo and follow a low polyphenolic diet * Participants will perform an intense resistance workout * Participants will have their blood drawn before and after the workout * Performance will be analyzed at 24, 48 and 72 hours after the workout

Recruiting
Paid Trial

Montana State University

Mary P Miles

Image of University of New Brunswick in Fredericton, Canada.

Mediterranean Diet for Toddler Health

24 - 36
All Sexes
Fredericton, Canada

Toddlerhood (ages 2-3) is a critical window when the gut microbiome is still developing and eating habits are being established. Yet, many Canadian toddlers eat diets high in sugar and salt, which may affect long-term health. This study will test whether a MED diet can improve dietary inflammation, gut health, and body composition in toddlers and whether a tailored nutrition education program for parents can help families maintain healthy eating patterns. In this study, toddlers will be randomly assigned to a 3-week MED diet or their usual diet. Families in the MED diet group will receive free meal boxes for the 3 weeks, plus guidance from a nutrition researcher through a structured education program. The standard diet group will continue their regular diet with general nutrition advice. Researchers will collect dietary information, body composition assessments, and stool samples to measure gut microbiome composition and metabolites. This first study of a controlled diet intervention in toddlers, combining behavioral support, high-quality food provision, and advanced gut microbiome analysis, will help understand how early diet shapes lifelong eating habits and health, guiding public health strategies and precision nutrition approaches to prevent chronic disease from early life.

Waitlist Available
Has No Placebo

University of New Brunswick

Dr. Maryam Kebbe, PhD, CLC

Have you considered Alrex clinical trials?

We made a collection of clinical trials featuring Alrex, we think they might fit your search criteria.
Go to Trials
Image of UConn Health in Farmington, United States.

Cognitive Remediation for Memory and Thinking Difficulties

18+
All Sexes
Farmington, CT

The goal of this clinical trial is to determine if a neuroscience-based computerized cognitive remediation ("brain training") program can treat neurocognitive dysfunction (i.e., memory or thinking difficulties) that emerges in some older adults following a viral infection. The main questions it aims to answer are: * Does computerized cognitive remediation improve cognitive performance and day-to-day functioning in older adults with postviral neurocognitive dysfunction? * Will treatment effects be maintained over time, leading to better long term cognitive outcomes? * Does the treatment lead to reductions in blood-based markers of inflammation as a potential mechanism of cognitive symptom improvement? * Can the treatment be optimized and refined based on feedback from participants to improve user (patient) experience? Researchers will compare the computerized cognitive remediation program to an active computer-based control condition (alternative computer activities) to see if the computerized cognitive remediation program works to treat postviral neurocognitive dysfunction. Participation takes approximately 43-48 hours over 7 months, with most activities (40-46 hours) completed within the first 7-8 weeks, including: * Initial intake visit: Eligibility confirmation (\~2-3 hours) * Computer activities: About 5 hours per week for \~6 weeks (total \~30 hours) completed on a computer tablet provided by the study and loaned to participants for use during the treatment phase * Weekly remote check-in meetings: \~30 minutes each during treatment * Blood draws: Two sessions (before and after treatment), \~20-30 minutes each * Three research visits: Pre-treatment, post-treatment, and 6-month follow-up (\~2-3 hours each, including assessments of cognitive, emotional, and daily functioning)

Recruiting
Has No Placebo

UConn Health

Cutter Lindbergh, Ph.D.

Image of Department of Nutritional Sciences in Storrs, United States.

Freeze-dried Grape Powder for Healthy Aging

50 - 75
All Sexes
Storrs, CT

The purpose of this study is to investigate the effects of consuming grape powder on immune profiles in healthy middle- and older-aged individuals. Specifically, the investigators are interested in evaluating the potential effects of grapes in influencing markers of immune function, inflammation, and metabolism that are known to change with aging. Grapes contain several nutrients and antioxidant polyphenols such as resveratrol, quercetin, vitamin K and fiber, which are known to promote heart and immune health. However, the effects of grapes on altering immune profiles within the context of aging is not well understood. Therefore, this study will explore how daily grape consumption impacts certain markers of immunity in healthy middle- and older-aged adults. The main study procedures include consumption of a freeze-dried grape powder and control powder (which tastes the same but has none of the grape compounds that are being studied) mixed with water as a beverage on a daily basis for 4 weeks each. The investigators will additionally ask that participants avoid eating grapes and certain other antioxidant/grape-related foods and beverages throughout the 13-week study. Participants will additionally be asked to complete surveys about their diet, physical activity, and medical history, as well as provide blood samples and body weight measures throughout the course of the study. Participation in the study is expected to last about 6.25 hours over the course of 13 weeks and will include 7 visits.

Recruiting
Paid Trial

Department of Nutritional Sciences

Have you considered Alrex clinical trials?

We made a collection of clinical trials featuring Alrex, we think they might fit your search criteria.
Go to Trials
Image of School of Public Health in Bloomington, United States.

High Salt Intake for High Blood Pressure

60 - 85
All Sexes
Bloomington, IN

Most Americans consume excess dietary salt based on the recommendations set by the American Heart Association and Dietary Guidelines for Americans. High dietary salt impairs blood pressure control by affecting systemic blood vessels and the kidneys. These changes contribute to excess salt consumption being associated with increased risk for chronic kidney disease and cardiovascular disease, the leading cause of death in America. Salt is particularly deleterious in older adults who are more likely to exhibit salt-sensitive hypertension. However, salt consumption remains high in the United States. Thus, there is a critical need for strategies to counteract the effects of high dietary salt as consumption is likely not going to decrease. One promising option is ketones, metabolites that are produced in the liver during prolonged exercise and very low-calorie diets. While exercise and low-calorie diets are beneficial, not many people engage in these activities. Limited evidence indicates that ketone supplements improve cardiovascular health in humans. Additionally, published rodent data indicates that ketone supplements prevent high salt-induced increases in blood pressure, blood vessel dysfunction, and kidney injury. Our human pilot data also indicates that high dietary salt reduces intrinsic ketone production, but it is unclear whether ketone supplementation confers humans' protection against high salt similar to rodents. Therefore, the investigators seek to conduct a short-term high-dietary salt study to determine whether ketone supplementation prevents high dietary salt from eliciting increased blood pressure, blood vessel dysfunction, and kidney injury/impaired blood flow. The investigators will also measure inflammatory markers in blood samples and isolate immune cells that control inflammation. Lastly, the investigators will also measure blood ketone concentration and other circulating metabolites that may be altered by high salt, which could facilitate novel therapeutic targets to combat high salt.

Recruiting
Has No Placebo

School of Public Health

Image of Tesla MedBed at Tampa-FL in Tampa, United States.

Biophoton Therapy for Stem Cell Proliferation

18 - 70
All Sexes
Tampa, FL

Study Objective The purpose of this clinical study is to evaluate if biophoton therapy, delivered by Tesla BioHealing® Biophoton Generators (Biophotonizer), can increase self-grown stem cells naturally. Study Design This is a randomized, double-blinded, placebo-controlled intervention clinical study to assess the effectiveness of biophoton therapy in impacting stem cells. Approximately 46 volunteers who want to increase self-grown stem cells will participate in the study. Study Randomization The biostatistician will prepare a randomization schedule including a serial of subject numbers. A subject number will be randomly assigned to each study participant, which will assign them to either the control group or the treatment group. Other than the Informed Consent Form (ICF), all study information will be recorded by using the subject number. The Principal Investigator, study physicians, study nurse, data-entry specialists, and biostatisticians, as well as the participants, will be blinded about who received which product during the first two weeks of study participation.

Recruiting
Online Trial

Tesla MedBed at Tampa-FL (+1 Sites)

James Z Liu, MD, PhD

Image of Goldring Center for High Performance Sport in Toronto, Canada.

Physical Activity for Delayed Onset Muscle Soreness

18 - 35
All Sexes
Toronto, Canada

After completing novel activity or exercise we may experience exercise-induced muscle damage (EIMD), resulting in a period of reduced muscle function and delayed onset muscle soreness (DOMS). DOMS is characterized by muscle pain and tenderness that typically resolves within a week. While the precise cause of DOMS is unknown, there is growing evidence implicating damage to the connective tissue that surrounds our muscle fibers and is related to a small amount of inflammation. This inflammation is a normal part of our body's ability to recovery from injuries and may be visualized through the use of ultrasound technology. A variety of recovery techniques have been proposed that may help with the recovery of DOMS such as massage and electrical muscle stimulation, but these are not always accessible. Therefore, we are interested in investigating whether the number of daily steps can affect how you experience DOMS.

Waitlist Available
Has No Placebo

Goldring Center for High Performance Sport

Have you considered Alrex clinical trials?

We made a collection of clinical trials featuring Alrex, we think they might fit your search criteria.
Go to Trials